Quanterix Corporation (NASDAQ: QTRX) Stock Competitors & Peer Comparison
See QTRX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for QTRX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QTRX | $3.03 | -3.04% | 144.6M | -1.21 | -$2.54 | N/A |
| ABT | $102.71 | +0.47% | 177.4B | 19.68 | $5.21 | +2.42% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $92.01 | -0.82% | 118B | 16.66 | $5.53 | +3.08% |
| SYK | $273.59 | -2.34% | 105.4B | 20.54 | $13.39 | +1.26% |
| BSX | $43.22 | -0.77% | 64.5B | 14.00 | $3.10 | N/A |
| EW | $88.53 | +0.32% | 50.8B | 32.69 | $2.70 | N/A |
| DXCM | $88.83 | +1.03% | 33.7B | 35.04 | $2.55 | N/A |
| GEHC | $64.48 | +0.05% | 29B | 14.06 | $4.56 | +0.22% |
| PHG | $24.96 | +1.13% | 24.1B | 14.10 | $1.75 | +4.01% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
QTRX vs ABT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ABT has a market cap of 177.4B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ABT trades at $102.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ABT's P/E ratio is 19.68. In terms of profitability, QTRX's ROE is -0.44%, compared to ABT's ROE of +0.11%. Regarding short-term risk, QTRX is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
QTRX vs BSX-PA Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, QTRX's ROE is -0.44%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, QTRX is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
QTRX vs MDT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, MDT has a market cap of 118B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while MDT trades at $92.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas MDT's P/E ratio is 16.66. In terms of profitability, QTRX's ROE is -0.44%, compared to MDT's ROE of +0.11%. Regarding short-term risk, QTRX is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
QTRX vs SYK Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SYK has a market cap of 105.4B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SYK trades at $273.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SYK's P/E ratio is 20.54. In terms of profitability, QTRX's ROE is -0.44%, compared to SYK's ROE of +0.16%. Regarding short-term risk, QTRX is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
QTRX vs BSX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BSX has a market cap of 64.5B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BSX trades at $43.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BSX's P/E ratio is 14.00. In terms of profitability, QTRX's ROE is -0.44%, compared to BSX's ROE of +0.15%. Regarding short-term risk, QTRX is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
QTRX vs EW Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, EW has a market cap of 50.8B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while EW trades at $88.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas EW's P/E ratio is 32.69. In terms of profitability, QTRX's ROE is -0.44%, compared to EW's ROE of +0.10%. Regarding short-term risk, QTRX is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
QTRX vs DXCM Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, DXCM has a market cap of 33.7B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while DXCM trades at $88.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas DXCM's P/E ratio is 35.04. In terms of profitability, QTRX's ROE is -0.44%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, QTRX is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
QTRX vs GEHC Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, GEHC has a market cap of 29B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while GEHC trades at $64.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas GEHC's P/E ratio is 14.06. In terms of profitability, QTRX's ROE is -0.44%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, QTRX is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
QTRX vs PHG Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, PHG has a market cap of 24.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while PHG trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas PHG's P/E ratio is 14.10. In terms of profitability, QTRX's ROE is -0.44%, compared to PHG's ROE of +0.10%. Regarding short-term risk, QTRX is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
QTRX vs ZBH Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ZBH has a market cap of 18.4B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ZBH trades at $94.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ZBH's P/E ratio is 11.25. In terms of profitability, QTRX's ROE is -0.44%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, QTRX is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
QTRX vs ABMD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ABMD's P/E ratio is 65.36. In terms of profitability, QTRX's ROE is -0.44%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, QTRX is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
QTRX vs SWAV Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SWAV's P/E ratio is 78.76. In terms of profitability, QTRX's ROE is -0.44%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, QTRX is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
QTRX vs PEN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while PEN trades at $317.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas PEN's P/E ratio is 82.93. In terms of profitability, QTRX's ROE is -0.44%, compared to PEN's ROE of +0.11%. Regarding short-term risk, QTRX is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
QTRX vs SNN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SNN has a market cap of 11.6B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SNN trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SNN's P/E ratio is 12.97. In terms of profitability, QTRX's ROE is -0.44%, compared to SNN's ROE of +0.12%. Regarding short-term risk, QTRX is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
QTRX vs ALGN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ALGN has a market cap of 10.7B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ALGN trades at $147.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ALGN's P/E ratio is 13.65. In terms of profitability, QTRX's ROE is -0.44%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, QTRX is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
QTRX vs BIO-B Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BIO-B has a market cap of 10.6B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BIO-B trades at $385.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BIO-B's P/E ratio is -67.94. In terms of profitability, QTRX's ROE is -0.44%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, QTRX is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
QTRX vs BIO Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BIO has a market cap of 10.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BIO trades at $375.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BIO's P/E ratio is 40.53. In terms of profitability, QTRX's ROE is -0.44%, compared to BIO's ROE of +0.03%. Regarding short-term risk, QTRX is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
QTRX vs GMED Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, GMED has a market cap of 10B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while GMED trades at $74.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas GMED's P/E ratio is 16.69. In terms of profitability, QTRX's ROE is -0.44%, compared to GMED's ROE of +0.12%. Regarding short-term risk, QTRX is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check GMED's competition here
Insulet Corp. (NASDAQ: PODD)
QTRX vs PODD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, PODD has a market cap of 9.7B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while PODD trades at $140.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas PODD's P/E ratio is 23.95. In terms of profitability, QTRX's ROE is -0.44%, compared to PODD's ROE of +0.27%. Regarding short-term risk, QTRX is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check PODD's competition here
Glaukos Corporation (NYSE: GKOS)
QTRX vs GKOS Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, GKOS has a market cap of 9.7B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while GKOS trades at $161.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas GKOS's P/E ratio is -190.27. In terms of profitability, QTRX's ROE is -0.44%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, QTRX is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check GKOS's competition here
Masimo Corporation (NASDAQ: MASI)
QTRX vs MASI Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas MASI's P/E ratio is 44.43. In terms of profitability, QTRX's ROE is -0.44%, compared to MASI's ROE of +0.09%. Regarding short-term risk, QTRX is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
QTRX vs BRKR Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BRKR has a market cap of 9.3B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BRKR trades at $62.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BRKR's P/E ratio is 30.85. In terms of profitability, QTRX's ROE is -0.44%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, QTRX is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
QTRX vs BRKRP Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BRKRP has a market cap of 9B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BRKRP trades at $456.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BRKRP's P/E ratio is 245.01. In terms of profitability, QTRX's ROE is -0.44%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, QTRX is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
QTRX vs HAE Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while HAE trades at $108.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas HAE's P/E ratio is 21.66. In terms of profitability, QTRX's ROE is -0.44%, compared to HAE's ROE of +0.11%. Regarding short-term risk, QTRX is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
QTRX vs NARI Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas NARI's P/E ratio is -59.24. In terms of profitability, QTRX's ROE is -0.44%, compared to NARI's ROE of -0.00%. Regarding short-term risk, QTRX is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
QTRX vs ITGR Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ITGR trades at $126.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ITGR's P/E ratio is 19.90. In terms of profitability, QTRX's ROE is -0.44%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, QTRX is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
QTRX vs LIVN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while LIVN trades at $77.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas LIVN's P/E ratio is 18.53. In terms of profitability, QTRX's ROE is -0.44%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, QTRX is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
QTRX vs AXNX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas AXNX's P/E ratio is -709.80. In terms of profitability, QTRX's ROE is -0.44%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, QTRX is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
QTRX vs IRTC Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while IRTC trades at $110.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas IRTC's P/E ratio is -254.26. In terms of profitability, QTRX's ROE is -0.44%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, QTRX is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check IRTC's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
QTRX vs TMDX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while TMDX trades at $88.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas TMDX's P/E ratio is 43.87. In terms of profitability, QTRX's ROE is -0.44%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, QTRX is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
QTRX vs NEOG Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, NEOG has a market cap of 2.8B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while NEOG trades at $13.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas NEOG's P/E ratio is 46.39. In terms of profitability, QTRX's ROE is -0.44%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, QTRX is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check NEOG's competition here
AxoGen, Inc. (NASDAQ: AXGN)
QTRX vs AXGN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, AXGN has a market cap of 2.4B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while AXGN trades at $45.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas AXGN's P/E ratio is 116.39. In terms of profitability, QTRX's ROE is -0.44%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, QTRX is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
QTRX vs INSP Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, INSP has a market cap of 2.2B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while INSP trades at $75.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas INSP's P/E ratio is 33.84. In terms of profitability, QTRX's ROE is -0.44%, compared to INSP's ROE of +0.18%. Regarding short-term risk, QTRX is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check INSP's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
QTRX vs UFPT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, UFPT has a market cap of 2.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while UFPT trades at $277.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas UFPT's P/E ratio is 28.26. In terms of profitability, QTRX's ROE is -0.44%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, QTRX is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
QTRX vs BFLY Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BFLY has a market cap of 2.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BFLY trades at $8.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BFLY's P/E ratio is -32.81. In terms of profitability, QTRX's ROE is -0.44%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, QTRX is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
QTRX vs NUVA Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas NUVA's P/E ratio is 75.00. In terms of profitability, QTRX's ROE is -0.44%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, QTRX is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
QTRX vs ESTA Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ESTA trades at $68.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ESTA's P/E ratio is -55.00. In terms of profitability, QTRX's ROE is -0.44%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, QTRX is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
QTRX vs NVCR Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while NVCR trades at $16.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas NVCR's P/E ratio is -12.84. In terms of profitability, QTRX's ROE is -0.44%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, QTRX is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
QTRX vs ATEC Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ATEC trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ATEC's P/E ratio is -169.67. In terms of profitability, QTRX's ROE is -0.44%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, QTRX is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
QTRX vs CNMD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CNMD trades at $44.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CNMD's P/E ratio is 10.00. In terms of profitability, QTRX's ROE is -0.44%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, QTRX is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
QTRX vs HSKA Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas HSKA's P/E ratio is -62.49. In terms of profitability, QTRX's ROE is -0.44%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, QTRX is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
QTRX vs IART Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while IART trades at $15.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas IART's P/E ratio is 6.45. In terms of profitability, QTRX's ROE is -0.44%, compared to IART's ROE of -0.01%. Regarding short-term risk, QTRX is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
QTRX vs AVNS Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas AVNS's P/E ratio is 27.77. In terms of profitability, QTRX's ROE is -0.44%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, QTRX is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
QTRX vs TNDM Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while TNDM trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas TNDM's P/E ratio is -18.14. In terms of profitability, QTRX's ROE is -0.44%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, QTRX is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check TNDM's competition here
Artivion, Inc. (NYSE: AORT)
QTRX vs AORT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while AORT trades at $23.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas AORT's P/E ratio is 38.85. In terms of profitability, QTRX's ROE is -0.44%, compared to AORT's ROE of -0.01%. Regarding short-term risk, QTRX is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check AORT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
QTRX vs SILK Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SILK's P/E ratio is -18.96. In terms of profitability, QTRX's ROE is -0.44%, compared to SILK's ROE of -0.35%. Regarding short-term risk, QTRX is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
QTRX vs FNA Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas FNA's P/E ratio is -19.83. In terms of profitability, QTRX's ROE is -0.44%, compared to FNA's ROE of -0.35%. Regarding short-term risk, QTRX is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check FNA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
QTRX vs PRCT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while PRCT trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas PRCT's P/E ratio is -9.95. In terms of profitability, QTRX's ROE is -0.44%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, QTRX is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
QTRX vs LMRI Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while LMRI trades at $10.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas LMRI's P/E ratio is -21.56. In terms of profitability, QTRX's ROE is -0.44%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, QTRX is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check LMRI's competition here
IRadimed Corporation (NASDAQ: IRMD)
QTRX vs IRMD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, IRMD has a market cap of 1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while IRMD trades at $82.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas IRMD's P/E ratio is 41.27. In terms of profitability, QTRX's ROE is -0.44%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, QTRX is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check IRMD's competition here
Enovis Corporation (NYSE: ENOV)
QTRX vs ENOV Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ENOV trades at $17.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ENOV's P/E ratio is 5.17. In terms of profitability, QTRX's ROE is -0.44%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, QTRX is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ENOV's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
QTRX vs BBNX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BBNX has a market cap of 984.8M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BBNX trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BBNX's P/E ratio is -13.27. In terms of profitability, QTRX's ROE is -0.44%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, QTRX is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
QTRX vs CBLL Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CBLL has a market cap of 924.7M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CBLL trades at $24.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CBLL's P/E ratio is -13.85. In terms of profitability, QTRX's ROE is -0.44%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, QTRX is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check CBLL's competition here
Bioventus Inc. (NASDAQ: BVS)
QTRX vs BVS Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BVS has a market cap of 874.6M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BVS trades at $13.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BVS's P/E ratio is 16.99. In terms of profitability, QTRX's ROE is -0.44%, compared to BVS's ROE of +0.28%. Regarding short-term risk, QTRX is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check BVS's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
QTRX vs CSII Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CSII's P/E ratio is -20.83. In terms of profitability, QTRX's ROE is -0.44%, compared to CSII's ROE of -0.14%. Regarding short-term risk, QTRX is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
QTRX vs INMD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, INMD has a market cap of 824.8M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while INMD trades at $14.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas INMD's P/E ratio is 9.97. In terms of profitability, QTRX's ROE is -0.44%, compared to INMD's ROE of +0.12%. Regarding short-term risk, QTRX is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check INMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
QTRX vs SIBN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SIBN has a market cap of 802.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SIBN trades at $18.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SIBN's P/E ratio is -53.21. In terms of profitability, QTRX's ROE is -0.44%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, QTRX is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SIBN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
QTRX vs AVR Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, AVR has a market cap of 793.4M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while AVR trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas AVR's P/E ratio is -4.21. In terms of profitability, QTRX's ROE is -0.44%, compared to AVR's ROE of -0.78%. Regarding short-term risk, QTRX is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check AVR's competition here
Varex Imaging Corporation (NASDAQ: VREX)
QTRX vs VREX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, VREX has a market cap of 778.4M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while VREX trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas VREX's P/E ratio is 19.46. In terms of profitability, QTRX's ROE is -0.44%, compared to VREX's ROE of +0.05%. Regarding short-term risk, QTRX is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
QTRX vs AHCO Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, AHCO has a market cap of 776.9M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while AHCO trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas AHCO's P/E ratio is 11.65. In terms of profitability, QTRX's ROE is -0.44%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, QTRX is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check AHCO's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
QTRX vs CTKB Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CTKB has a market cap of 684.5M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CTKB trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CTKB's P/E ratio is -28.08. In terms of profitability, QTRX's ROE is -0.44%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, QTRX is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check CTKB's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
QTRX vs SSII Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SSII has a market cap of 652.4M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SSII trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SSII's P/E ratio is -63.58. In terms of profitability, QTRX's ROE is -0.44%, compared to SSII's ROE of -0.27%. Regarding short-term risk, QTRX is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
QTRX vs SRDX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SRDX's P/E ratio is -34.66. In terms of profitability, QTRX's ROE is -0.44%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, QTRX is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
QTRX vs APEN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas APEN's P/E ratio is -9.43. In terms of profitability, QTRX's ROE is -0.44%, compared to APEN's ROE of -0.85%. Regarding short-term risk, QTRX is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
QTRX vs KIDS Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, KIDS has a market cap of 560.4M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while KIDS trades at $22.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas KIDS's P/E ratio is -18.49. In terms of profitability, QTRX's ROE is -0.44%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, QTRX is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
QTRX vs DCTH Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, DCTH has a market cap of 556.1M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while DCTH trades at $15.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas DCTH's P/E ratio is 1611.00. In terms of profitability, QTRX's ROE is -0.44%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, QTRX is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
QTRX vs ZIMV Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, QTRX's ROE is -0.44%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, QTRX is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
QTRX vs CERS Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CERS has a market cap of 534M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CERS trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CERS's P/E ratio is -52.89. In terms of profitability, QTRX's ROE is -0.44%, compared to CERS's ROE of -0.10%. Regarding short-term risk, QTRX is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
QTRX vs TCMD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, TCMD has a market cap of 500.7M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while TCMD trades at $22.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas TCMD's P/E ratio is 20.56. In terms of profitability, QTRX's ROE is -0.44%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, QTRX is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
QTRX vs NPCE Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, NPCE has a market cap of 486.9M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while NPCE trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas NPCE's P/E ratio is -25.05. In terms of profitability, QTRX's ROE is -0.44%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, QTRX is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
QTRX vs SGHT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SGHT has a market cap of 436.4M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SGHT trades at $8.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SGHT's P/E ratio is -14.32. In terms of profitability, QTRX's ROE is -0.44%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, QTRX is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SGHT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
QTRX vs PACB Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, PACB has a market cap of 425.5M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while PACB trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas PACB's P/E ratio is -3.34. In terms of profitability, QTRX's ROE is -0.44%, compared to PACB's ROE of -49.62%. Regarding short-term risk, QTRX is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check PACB's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
QTRX vs CLPT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CLPT has a market cap of 414.8M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CLPT trades at $13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CLPT's P/E ratio is -11.72. In terms of profitability, QTRX's ROE is -0.44%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, QTRX is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
QTRX vs SENS Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SENS has a market cap of 400.4M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SENS trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SENS's P/E ratio is -4.30. In terms of profitability, QTRX's ROE is -0.44%, compared to SENS's ROE of -1.66%. Regarding short-term risk, QTRX is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
QTRX vs OFIX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, OFIX has a market cap of 352.1M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while OFIX trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas OFIX's P/E ratio is -5.67. In terms of profitability, QTRX's ROE is -0.44%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, QTRX is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
QTRX vs CV Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CV has a market cap of 334.8M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CV trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CV's P/E ratio is -10.63. In terms of profitability, QTRX's ROE is -0.44%, compared to CV's ROE of -1.78%. Regarding short-term risk, QTRX is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check CV's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
QTRX vs CATX Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, CATX has a market cap of 327.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while CATX trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas CATX's P/E ratio is -2.16. In terms of profitability, QTRX's ROE is -0.44%, compared to CATX's ROE of -0.42%. Regarding short-term risk, QTRX is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
QTRX vs TLSI Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, TLSI has a market cap of 314M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while TLSI trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas TLSI's P/E ratio is -3.04. In terms of profitability, QTRX's ROE is -0.44%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, QTRX is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check TLSI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
QTRX vs SMLR Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas SMLR's P/E ratio is 3.92. In terms of profitability, QTRX's ROE is -0.44%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, QTRX is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
QTRX vs TMCI Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, TMCI has a market cap of 291.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while TMCI trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas TMCI's P/E ratio is -4.78. In terms of profitability, QTRX's ROE is -0.44%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, QTRX is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check TMCI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
QTRX vs RCEL Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, RCEL has a market cap of 273.8M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while RCEL trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas RCEL's P/E ratio is -7.65. In terms of profitability, QTRX's ROE is -0.44%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, QTRX is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
QTRX vs INFU Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, INFU has a market cap of 258.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while INFU trades at $12.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas INFU's P/E ratio is 31.22. In terms of profitability, QTRX's ROE is -0.44%, compared to INFU's ROE of +0.15%. Regarding short-term risk, QTRX is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
QTRX vs MGRM Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas MGRM's P/E ratio is -12.00. In terms of profitability, QTRX's ROE is -0.44%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, QTRX is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
QTRX vs NVRO Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas NVRO's P/E ratio is -1.91. In terms of profitability, QTRX's ROE is -0.44%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, QTRX is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
QTRX vs ELMD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ELMD has a market cap of 218.5M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ELMD trades at $27.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ELMD's P/E ratio is 20.15. In terms of profitability, QTRX's ROE is -0.44%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, QTRX is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check ELMD's competition here
RxSight, Inc. (NASDAQ: RXST)
QTRX vs RXST Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, RXST has a market cap of 215.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while RXST trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas RXST's P/E ratio is -4.60. In terms of profitability, QTRX's ROE is -0.44%, compared to RXST's ROE of -0.17%. Regarding short-term risk, QTRX is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check RXST's competition here
Profound Medical Corp. (NASDAQ: PROF)
QTRX vs PROF Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, PROF has a market cap of 212.9M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while PROF trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas PROF's P/E ratio is -5.98. In terms of profitability, QTRX's ROE is -0.44%, compared to PROF's ROE of -0.56%. Regarding short-term risk, QTRX is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check PROF's competition here
Neuronetics, Inc. (NASDAQ: STIM)
QTRX vs STIM Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, STIM has a market cap of 201.8M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while STIM trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas STIM's P/E ratio is -6.59. In terms of profitability, QTRX's ROE is -0.44%, compared to STIM's ROE of -1.51%. Regarding short-term risk, QTRX is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
QTRX vs BSGM Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas BSGM's P/E ratio is -5.81. In terms of profitability, QTRX's ROE is -0.44%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, QTRX is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
QTRX vs MDGS Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas MDGS's P/E ratio is -0.27. In terms of profitability, QTRX's ROE is -0.44%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, QTRX is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
QTRX vs QIPT Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas QIPT's P/E ratio is -15.87. In terms of profitability, QTRX's ROE is -0.44%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, QTRX is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
QTRX vs FOCL Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, FOCL has a market cap of 155.6M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while FOCL trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas FOCL's P/E ratio is -4.01. In terms of profitability, QTRX's ROE is -0.44%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, QTRX is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check FOCL's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
QTRX vs LUCD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, LUCD has a market cap of 149.9M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while LUCD trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas LUCD's P/E ratio is -2.12. In terms of profitability, QTRX's ROE is -0.44%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, QTRX is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for QTRX.Check LUCD's competition here
Quantum-Si incorporated (NASDAQ: QSI)
QTRX vs QSI Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, QSI has a market cap of 147.4M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while QSI trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas QSI's P/E ratio is -1.62. In terms of profitability, QTRX's ROE is -0.44%, compared to QSI's ROE of -0.47%. Regarding short-term risk, QTRX is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
QTRX vs INGN Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, INGN has a market cap of 139.2M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while INGN trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas INGN's P/E ratio is -5.65. In terms of profitability, QTRX's ROE is -0.44%, compared to INGN's ROE of -0.13%. Regarding short-term risk, QTRX is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
QTRX vs ICAD Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ICAD's P/E ratio is -20.37. In terms of profitability, QTRX's ROE is -0.44%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, QTRX is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
QTRX vs ECOR Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ECOR has a market cap of 105.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ECOR trades at $11.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ECOR's P/E ratio is -6.95. In terms of profitability, QTRX's ROE is -0.44%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, QTRX is more volatile compared to ECOR. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
QTRX vs HJLI Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas HJLI's P/E ratio is N/A. In terms of profitability, QTRX's ROE is -0.44%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, QTRX is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
QTRX vs ASXC Comparison September 2026
Quanterix Corporation (NASDAQ: QTRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QTRX stands at 144.6M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, QTRX is priced at $3.03 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QTRX currently has a P/E ratio of -1.21, whereas ASXC's P/E ratio is -1.12. In terms of profitability, QTRX's ROE is -0.44%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, QTRX is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for QTRX.Check ASXC's competition here